HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

tenoxicam

Also Known As:

4-hydroxy-2-methyl-N-2-pyridyl-2H-thieno(2,3-e)-1,2-thiazine-3-carboxamide 1,1-dioxide; Apo-Tenoxicam; Apotex brand of tenoxicam; Artriunic; Mobiflex; Novag brand of tenoxicam; Novo-Tenoxicam; Novopharm brand of tenoxicam; Reutenox; Ro 12-0068; Ro-12-0068; Roche brand of tenoxicam; Solvay brand of tenoxicam; Tilcotil

Networked: 235 relevant articles (40 outcomes, 74 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Sun, Wei-Zen: 3 articles (09/2005 - 04/2002)
2.	Elhakim, M: 3 articles (09/2000 - 05/2000)
3.	Yaylak, Faik: 2 articles (10/2015 - 11/2004)
4.	Simsek, Tuncer: 2 articles (09/2015 - 09/2015)
5.	Kiraz, Hasan Ali: 2 articles (09/2015 - 09/2015)
6.	Sahin, Hasan: 2 articles (09/2015 - 09/2015)
7.	Erbas, Mesut: 2 articles (09/2015 - 09/2015)
8.	Toman, Huseyin: 2 articles (09/2015 - 09/2015)
9.	Lin, Chen-Jung: 2 articles (01/2003 - 04/2002)
10.	Chen, Li-Kuei: 2 articles (01/2003 - 04/2002)

Related Diseases

1.	Pain (Aches) 11/01/1996 - "Tenoxicam treated patients improved more than placebo-injected patients in a statistically highly significant manner with regard to clinical index, pain on VAS during active movement and at rest, active mobility (degrees), pain or pressure and clinical global impression (assessed by investigator and patient). " 11/08/1989 - "Subjective assessments of overall efficacy, pain at night, pain on movement and stiffness made before treatment and at 1, 3 and 6 months posttreatment showed that tenoxicam significantly improved all parameters. " 11/01/1996 - "These results indicate that tenoxicam 20 mg injected locally is effective in alleviating pain and in improving shoulder mobility in patients with a painful shoulder episode and suggest that such a treatment is safe and well tolerated. " 01/01/1985 - "Both drugs improved general pain, improvement being greater with tenoxicam. " 01/01/1985 - "The results showed that both drugs improved general pain, the improvement being somewhat greater with tenoxicam. "
2.	Postoperative Pain 04/01/1990 - "The efficacy of a new nonsteroidal anti-inflammatory agent, Tenoxicam, was valued in a study of 58 patients distinguished into 3 groups, group A consist of 29 patients with inflammatory diseases of the mouth, group 1B and 2B (29 patients) with acute postoperative pain. " 01/01/2009 - "In the absence of evidence of efficacy for oral tenoxicam in acute postoperative pain, its use in this indication is not justified at present. " 01/01/2009 - "To assess the efficacy of single dose oral tenoxicam in acute postoperative pain, and any associated adverse events. " 11/01/1994 - "To assess safety and efficacy of tenoxicam for postoperative pain relief after cesarean delivery. " 01/01/2009 - "Not one of sixteen studies identified by the searches and examined in detail studied oral tenoxicam in patients with established postoperative pain and therefore no results are available. "
3.	Osteoarthritis 01/01/1993 - "In another study, thirty patients with chronic osteoarthritis were randomly assigned to receive PBC or tenoxicam daily for eight weeks. " 09/01/2015 - "Tenoxicam is widely used in osteoarthritis treatment and we aimed to compare the effectivity of oral and intra-articular administration of tenoxicam in osteoarthritis treatment. " 09/01/2015 - "Tenoxicam is widely used in osteoarthritis treatment and we aimed to compare the effectivity of oral and intra-articular administration of tenoxicam in osteoarthritis treatment. " 01/01/2015 - "Intra-articular application of HA, tenoxicam and Vit E are chondroprotective in early osteoarthritis model in rats. " 11/01/1994 - "Intra-articular use of tenoxicam in degenerative osteoarthritis of the knee joint."
4.	Rheumatoid Arthritis 01/01/1989 - "The efficacy of tenoxicam in patients suffering from rheumatoid arthritis (including assessments of quantified articular scintigraphic data)." 01/01/1987 - "Long-term study with tenoxicam in rheumatoid arthritis." 01/01/1987 - "Long-term treatment of rheumatoid arthritis: results of a two-year study with tenoxicam." 01/01/1996 - "As regards patients with rheumatoid arthritis, granular tenoxicam of a twenty-miligram dose daily showed both a good clinical effectiveness and a good bearing in long-term medicine taking, rarely causing gastrointestinal side effects, compared to other nonsteroidal antiinflammatory drugs in peroral taking." 03/01/1994 - "Using a modified Boyden chambers method, polymorphonuclear leucocyte (pmnl) random migration and chemotactic responsiveness were compared in 20 rheumatoid arthritis patients with that of 10 healthy controls receiving tenoxicam. "
5.	Ankylosing Spondylitis 01/01/1987 - "Tenoxicam (Ro 12-0068) in ankylosing spondylitis." 07/01/1996 - "Aceclofenac is as safe and effective as tenoxicam in the treatment of ankylosing spondylitis: a 3 month multicenter comparative trial. " 07/01/1996 - "To compare in a 3 month, multicenter, double blind, parallel study the efficacy and safety of a nonsteroidal antiinflammatory drug, aceclofenac, 100 mg bid orally, with that of tenoxicam, 20 mg orally at bedtime, in the treatment of adult patients with active ankylosing spondylitis (AS). " 01/01/1990 - "A randomized study was performed on 24 patients with ankylosing spondylitis to compare the efficacy and tolerability of 20 mg tenoxicam daily with 50 mg diclofenac twice daily. " 01/01/1986 - "Tenoxicam (20 mg/day) and piroxicam (20 mg/day) were compared in a double-blind, parallel group study over 4 weeks in 30 patients with ankylosing spondylitis. "

Related Drugs and Biologics

1.	Indomethacin (Indometacin)
2.	aceclofenac
3.	Piroxicam (Feldene)
4.	Naproxen (Naprosyn)
5.	Acetaminophen (Paracetamol)
6.	lornoxicam
7.	Creatinine
8.	Diclofenac (SR 38)
9.	Morphine (MS Contin)
10.	Ketoprofen (Orudis)

Related Therapies and Procedures

1.	Analgesia
2.	Laparoscopic Cholecystectomy
3.	Tonsillectomy
4.	Injections
5.	Hysterectomy